# FGL2/Fibroleukin and Hepatitis C Virus Recurrence Post Liver Transplantation

> **NCT00701272** · — · UNKNOWN · sponsor: **University Health Network, Toronto** · enrollment: 70 (estimated)

## Conditions studied

- Liver Transplantation
- Hepatitis C

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00701272
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-06
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2013-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00701272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00701272, "FGL2/Fibroleukin and Hepatitis C Virus Recurrence Post Liver Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00701272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*